gptkbp:instanceOf
|
gptkb:disease
|
gptkbp:affects
|
adults
elderly
ears
face
eyes
mouth
immunocompromised individuals
any part of the body
|
gptkbp:alsoKnownAs
|
herpes zoster
|
gptkbp:annualIncidence
|
1 in 1000 people
|
gptkbp:annualIncidenceOver50
|
1 in 100 people
|
gptkbp:causedBy
|
gptkb:varicella-zoster_virus
|
gptkbp:commonIn
|
older adults
one side of the torso
|
gptkbp:complication
|
gptkb:Ramsay_Hunt_syndrome
gptkb:pneumonia
skin infections
hearing loss
vision loss
encephalitis
postherpetic neuralgia
motor neuropathy
|
gptkbp:diagnosedBy
|
clinical examination
PCR test
viral culture
|
gptkbp:duration
|
2 to 4 weeks
|
gptkbp:firstDescribed
|
18th century
|
https://www.w3.org/2000/01/rdf-schema#label
|
shingles (herpes zoster)
|
gptkbp:ICD-10_code
|
gptkb:B02
|
gptkbp:MeSH_ID
|
D006562
|
gptkbp:prevention
|
gptkb:Shingrix
gptkb:Zostavax
shingles vaccine
|
gptkbp:reactivationOf
|
gptkb:varicella-zoster_virus
|
gptkbp:recurrence
|
rarely
|
gptkbp:relatedTo
|
gptkb:chickenpox
|
gptkbp:riskFactor
|
gptkb:cancer
gptkb:HIV/AIDS
stress
weakened immune system
age over 50
|
gptkbp:symptom
|
itching
tingling
blisters
burning sensation
painful rash
|
gptkbp:transmission
|
can cause chickenpox in non-immune individuals
not directly contagious
|
gptkbp:treatment
|
gptkb:famciclovir
gptkb:valacyclovir
gptkb:acyclovir
antiviral drugs
pain relievers
|
gptkbp:virusRemainsDormantIn
|
nerve tissue
|
gptkbp:bfsParent
|
gptkb:Chickenpox
|
gptkbp:bfsLayer
|
5
|